Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Modified BuCy Vs BEAM Followed By Autologous Stem Cell Transplantation in Lymphoma: Case Pair Comparative Analysis on Toxicity and Efficacy

Haiwen Huang, MD, Lihong Zhang, Yibin Jiang, Zhengming Jin, Depei Wu, MD

Blood (2017) 130 (Supplement 1): 5525.

https://doi.org/10.1182/blood.V130.Suppl_1.5525.5525

Published: 2017

Journal Articles

Low-Dose ATG Combined with Facybu Conditioning Regimen Followed By Single Unrelated Cord Blood Transplantation in Hematological Malignancies

Yating Jiang, Xiaofan Li, MD PhD, Jiafu Huang, Zheng Jing, Haiying Fu, Jianda Hu, Prof MDPhD, Yuanzhong Chen, Nainong LI

Blood (2017) 130 (Supplement 1): 5552.

https://doi.org/10.1182/blood.V130.Suppl_1.5552.5552

Published: 2017

Journal Articles

Improved Outcome of Haploidentical Peripheral Blood Stem Cell Transplant Treating Severe Aplastic Anemia

Stephen Yang Liang, MD

Blood (2017) 130 (Supplement 1): 3227.

https://doi.org/10.1182/blood.V130.Suppl_1.3227.3227

Published: 2017

Journal Articles

Low-Dose Decitabine Combined with Modified Bucy Is More Effective Conditioning Regimen for High-Risk Patients with Acute Myeloid Leukaemia/Myelodysplastic Syndrome

Xiaowen Tang, MD, Jing Cao, Xiaojing Shi, Ling Ge, Aining Sun, PhD, Xiaming Zhu, Huiying Qiu, Zhengming Jin, Miao Miao, Chengcheng Fu, Xiao Ma, Feng Chen, Shengli Xue, Yue Han, MD, Mengxing Xue, Xinliang Mao, PhD, Depei Wu, MD PhD

Blood (2016) 128 (22): 5750.

https://doi.org/10.1182/blood.V128.22.5750.5750

Published: 2016

Journal Articles

Clinical Outcomes of Haploidentical Donor Compared with Unrelated and HLA-Matched Related Donor Hematopoietic Stem Cell Transplantation for Hematologic Malignancies

Yi Luo, Yamin Tan, Xiaoyu Lai, Weiyan Zheng, Ph.D., Jimin Shi, Gaofeng Zheng, M.Med, He Huang, M.D.; Ph.D.

Blood (2012) 120 (21): 4159.

https://doi.org/10.1182/blood.V120.21.4159.4159

Published: 2012

Journal Articles

Safety and Efficacy of High-Dose Cyclophosphamide, Etoposide, and Ranimustine (CEM) Regimen Followed by Autologous Peripheral Blood Stem Cell Transplantation for Patients with High Risk De Novo Diffuse Large B-Cell Lymphoma or Diffuse Large B-Cell Lymphoma Associated with Follicular Lymphoma.

Blood (2012) 120 (21): 3121.

https://doi.org/10.1182/blood.V120.21.3121.3121

Published: 2012

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation From HBsAg-Positive Donors Into HBsAg-Negative Recipients: A Safety and Practicable Regimen Under Active Prophylactic Anti-HBV Therapy

Yongxian Hu, Yi Luo, Yamin Tan, Xiaoyu Lai, Jimin Shi, Jingsong He, Gaofeng Zheng, Weiyan Zheng, Wanzhuo Xie, Zhen Cai, He Huang

Blood (2011) 118 (21): 1949.

https://doi.org/10.1182/blood.V118.21.1949.1949

Published: 2011

Journal Articles

Safety, Feasibility and Efficacy of High Dose Ranimustine (MCNU), Carboplatin, Etoposide, and Cyclophosphamide (MCVC) Therapy Followed by Autologous Stem Cell Transplantation for Malignant Lymphoma.

Yoshihiro Kameoka, MD, PhD, Naoto Takahashi, MD, PhD, Kenichi Ishizawa, MD, PhD, Kazunori Murai, MD, PhD, Yuichi Kato, MD, PhD, Hideyoshi Noji, MD, PhD, Jugo Ito, MD, PhD, Makoto Hirokawa, MD, PhD, Katsusi Tajima, MD, PhD, Tsutomu Shichishima, MD, PhD, Yoji Ishida, MD, PhD, Hideo Harigae, MD, PhD, Kenichi Sawada, MD, PhD

Blood (2010) 116 (21): 4588.

https://doi.org/10.1182/blood.V116.21.4588.4588

Published: 2010

Journal Articles

HLA-Haploidentical Stem Cell Transplantation for Malignant Hematological Diseases Using G-CSF Mobilized Bone Marrow and Peripheral Blood Stem Cells

Yi Luo, Yamin Tan, Xiaoyu Lai, Jimin Shi, Weiyan Zheng, He Huang, MD, PhD

Blood (2010) 116 (21): 2384.

https://doi.org/10.1182/blood.V116.21.2384.2384

Published: 2010

Journal Articles

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Jianyu Weng, MD, Xin Du, PhD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, PhD, Liye Zhong, MD, Miaorong She, PhD, Chengxin Deng, Wei Ling, PhD, Xiaoli Zou, Qunhua Li, Wei Lin, Zhixin Huang

Blood (2009) 114 (22): 1147.

https://doi.org/10.1182/blood.V114.22.1147.1147

Published: 2009

Journal Articles

Cytoreductive Regimen Containing Ranimustine (MCNU),Carboplatin, Etoposide and Cyclophosphamide (MCEC) Before Autologous Peripheral Blood Stem Cell Transplantation for Relapsed or Refractory Lymphoma

Yoshitaka Asakura, MD, Ryuji Tanosaki, MD, Sung-Won Kim, MD, Teruhisa Azuma, MD, Saiko Kurosawa, MD, Kimikazu Yakushijin, MD, Dai Maruyama, MD, Shin-ichiro Mori, MD, Takahiro Fukuda, MD, Takashi Watanabe, MD, Yukio Kobayashi, MD, PhD, Kensei Tobinai, MD, PhD, Yoichi Takaue, MD

Blood (2008) 112 (11): 4448.

https://doi.org/10.1182/blood.V112.11.4448.4448

Published: 2008

Journal Articles

Comparison of Immune Reconstitution after Unmanipulated HLA-Mismatched/Haploidentical Blood and Marrow Transplantation and Unmanipulated HLA-Matched Sibling Transplantation in Patients with Hematological Malignancies.

Ying jun Chang, Xiang yu Zhao, Ming rui Huo, Xiao hua Luo, Lan ping Xu, Dai hong Liu, Kai yan Liu, Xiao Jun Huang, MD, PhD

Blood (2008) 112 (11): 2221.

https://doi.org/10.1182/blood.V112.11.2221.2221

Published: 2008

Journal Articles

HLA Mismatched/Haploidentical Haematopoietic Stem Cell Transplantation for the Treatment of Chronic Myelogenous Leukemia.

Xiao Jun Huang, Lan-ping Xu, Kai-yan Liu, Dai-hong Liu, Huan Chen, Wei Han, Yu-hong Chen, Jing-zhi Wang, Yao Chen, Xiao-hui Zhang, Hong-xia Shi, Dao-pei Lu

Blood (2006) 108 (11): 3154.

https://doi.org/10.1182/blood.V108.11.3154.3154

Published: 2006

Journal Articles

A Comparison of Clinical Outcomes of Non-T-Cell-Depleted (Non-TCD) Unrelated Donor Heamatopietic Stem Cell Transplantation (HSCT) and Non-TCD Haploidentical Related Donor HSCT.

Feng Chen, MD, De Pei Wu, MD, Aining Sun, MD, Xiao Ma, MD, Xiaowen Tang, MD, Xiaojing Wu, MA, Ying Wang, MA

Blood (2006) 108 (11): 5140.

https://doi.org/10.1182/blood.V108.11.5140.5140

Published: 2006

Journal Articles

The Effect of HLA-Cw in Haploidentical Stem Cell Transplantation.

Mingzhen Yang, MD, De Pei Wu, MD, Ying Wang, MA, Xiaojin Wu, MA

Blood (2006) 108 (11): 5147.

https://doi.org/10.1182/blood.V108.11.5147.5147

Published: 2006

Journal Articles

Clinical Research of Autologous Hematopoietic Stem Cell Transplantation for Hematological Malignancies and Solid Tumors.

Zhen-qian Huang, Dong-hua Zhang, Huo Tan, Cheng-zhi Zhou, Dan Liu, Huan-zhu Zhang, Jie-xia Zhang, Wei Huang, Wen-li Liu

Blood (2005) 106 (11): 5475.

https://doi.org/10.1182/blood.V106.11.5475.5475

Published: 2005

Journal Articles

The Overview of the Short Term Curative Effects of HLA Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies.

Jian Ouyang, MD, Bing Chen, MD, Yonggong Yang, MD, Jingyan Xu, BD, Xiaoyan Shao, MD

Blood (2005) 106 (11): 5440.

https://doi.org/10.1182/blood.V106.11.5440.5440

Published: 2005

Journal Articles

Clinical Study on Patients with Advanced Malignant Hematopoietic Disease by Non-T Cell Depleted Haploidentical Hematopoietic Stem Cells Transplantation.

Mingzhen Yang, MD, PhD, Ying Wang, PhD, Xiao Ma, PhD, Aining Sun, PhD, De Pei Wu, MD.Ph.D.

Blood (2005) 106 (11): 5451.

https://doi.org/10.1182/blood.V106.11.5451.5451

Published: 2005

Journal Articles

Subclinical Alterations in Coagulation in Patients during Conditioning Regimen before Allogeneic Hematopoietic Stem Cell Transplantation.

Qian Jiang, Xiao Jun Huang, Kaiyan Liu, Huan Chen, Yuhong Chen, Zhiyong Cao, Daopei Lu

Blood (2005) 106 (11): 5292.

https://doi.org/10.1182/blood.V106.11.5292.5292

Published: 2005

Journal Articles

Late Onset Neutropenia and Decreased Immunoglobulin Concentration after Rituximab Combined Autotransplantation for B Cell Lymphoma.

Yasuo Hirayama, Kyuhei Kohda, Yasuji Hirata, Hiroyuki Kuroda, Takuya Matsunaga, Yuichi Konuma, Makoto Yoshida, Toshiro Sakai, Yoshiro Niitsu

Blood (2005) 106 (11): 5347.

https://doi.org/10.1182/blood.V106.11.5347.5347

Published: 2005

NARROW

Modified BuCy Vs BEAM Followed By Autologous Stem Cell Transplantation in Lymphoma: Case Pair Comparative Analysis on Toxicity and Efficacy

Low-Dose ATG Combined with Facybu Conditioning Regimen Followed By Single Unrelated Cord Blood Transplantation in Hematological Malignancies

Improved Outcome of Haploidentical Peripheral Blood Stem Cell Transplant Treating Severe Aplastic Anemia

Low-Dose Decitabine Combined with Modified Bucy Is More Effective Conditioning Regimen for High-Risk Patients with Acute Myeloid Leukaemia/Myelodysplastic Syndrome

Clinical Outcomes of Haploidentical Donor Compared with Unrelated and HLA-Matched Related Donor Hematopoietic Stem Cell Transplantation for Hematologic Malignancies

Safety and Efficacy of High-Dose Cyclophosphamide, Etoposide, and Ranimustine (CEM) Regimen Followed by Autologous Peripheral Blood Stem Cell Transplantation for Patients with High Risk De Novo Diffuse Large B-Cell Lymphoma or Diffuse Large B-Cell Lymphoma Associated with Follicular Lymphoma.

Allogeneic Hematopoietic Stem Cell Transplantation From HBsAg-Positive Donors Into HBsAg-Negative Recipients: A Safety and Practicable Regimen Under Active Prophylactic Anti-HBV Therapy

Safety, Feasibility and Efficacy of High Dose Ranimustine (MCNU), Carboplatin, Etoposide, and Cyclophosphamide (MCVC) Therapy Followed by Autologous Stem Cell Transplantation for Malignant Lymphoma.

HLA-Haploidentical Stem Cell Transplantation for Malignant Hematological Diseases Using G-CSF Mobilized Bone Marrow and Peripheral Blood Stem Cells

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Cytoreductive Regimen Containing Ranimustine (MCNU),Carboplatin, Etoposide and Cyclophosphamide (MCEC) Before Autologous Peripheral Blood Stem Cell Transplantation for Relapsed or Refractory Lymphoma

Comparison of Immune Reconstitution after Unmanipulated HLA-Mismatched/Haploidentical Blood and Marrow Transplantation and Unmanipulated HLA-Matched Sibling Transplantation in Patients with Hematological Malignancies.

HLA Mismatched/Haploidentical Haematopoietic Stem Cell Transplantation for the Treatment of Chronic Myelogenous Leukemia.

A Comparison of Clinical Outcomes of Non-T-Cell-Depleted (Non-TCD) Unrelated Donor Heamatopietic Stem Cell Transplantation (HSCT) and Non-TCD Haploidentical Related Donor HSCT.

The Effect of HLA-Cw in Haploidentical Stem Cell Transplantation.

Clinical Research of Autologous Hematopoietic Stem Cell Transplantation for Hematological Malignancies and Solid Tumors.

The Overview of the Short Term Curative Effects of HLA Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies.

Clinical Study on Patients with Advanced Malignant Hematopoietic Disease by Non-T Cell Depleted Haploidentical Hematopoietic Stem Cells Transplantation.

Subclinical Alterations in Coagulation in Patients during Conditioning Regimen before Allogeneic Hematopoietic Stem Cell Transplantation.

Late Onset Neutropenia and Decreased Immunoglobulin Concentration after Rituximab Combined Autotransplantation for B Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only